ESTROMINATE Trademark

Trademark Overview


On Thursday, June 27, 2024, a trademark application was filed for ESTROMINATE with the United States Patent and Trademark Office. The USPTO has given the ESTROMINATE trademark a serial number of 98622400. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, November 12, 2024. This trademark is owned by Chaos and Pain LLC. The ESTROMINATE trademark is filed in the Pharmaceutical Products category with the following description:

Dietary and nutritional supplements

General Information


Serial Number98622400
Word MarkESTROMINATE
Filing DateThursday, June 27, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, November 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements


Goods and ServicesDietary and nutritional supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 27, 2024
Primary Code005
First Use Anywhere DateSunday, June 23, 2024
First Use In Commerce DateSunday, June 23, 2024

Trademark Owner History


Party NameChaos and Pain LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBirmingham, AL 35242

Trademark Events


Event DateEvent Description
Thursday, June 27, 2024NEW APPLICATION ENTERED
Thursday, June 27, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 4, 2024ASSIGNED TO EXAMINER
Tuesday, November 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED